Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization
{{output}}
Background: Despite proven benefits of low-density lipoprotein cholesterol (LDL-C) lowering in secondary prevention of atherosclerotic cardiovascular disease, goal achievement remains suboptimal. ... ...
